Montelukast Granules 4mg (Montelukast Sodium)
Montelukast Sodium 4.16mg
Prescription medication
NBK Pharmaceutical Co., Ltd.
MFDS item code 202002914 · Approved 2020.04.23
This product's status changed to Approval withdrawn on 2024.07.25. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Prevention and treatment of asthma; relief of seasonal and perennial allergic rhinitis symptoms
This medication is used to prevent asthma and assist in continued treatment. It is also used to alleviate the symptoms of seasonal and perennial allergic rhinitis.
This medicine is taken once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the time of administration should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 packet once daily in the evening. ○ How to take the fine granules The 4 mg fine granules may be taken orally directly or mixed with a small amount (about 5 mL) of soft food at or below room temperature, such as infant food, breast milk, or porridge. Do not open the package until immediately before use. After opening, immediately (within 15 minutes) mix the contents with infant food, breast milk, or food, or take the entire contents directly. Do not leave this medicine mixed with infant food, breast milk, or food for an extended period; discard any remainder. This formulation is not intended to be mixed with beverages other than infant food or breast milk, but a beverage may be taken immediately after administration. This medicine may be taken without regard to meals.
Asthma Children 2~5 years: Administer montelukast 4 mg orally once daily. Infants 12 months to under 2 years: Administer this medicine 4 mg orally once daily in the evening. The efficacy and safety of this medicine for asthma have not been established in infants under 12 months of age. Allergic rhinitis Children 2~5 years: Administer montelukast 4 mg orally once daily. The efficacy and safety of this medicine for seasonal allergic rhinitis have not been established in infants under 2 years of age. Infants 6 months to under 2 years: Administer this medicine 4mg orally once daily. The efficacy and safety of this medicine for perennial allergic rhinitis have not been established in infants under 6 months of age.
This medication should not be used in patients allergic to this medication or its components. Fatigue, fever, abdominal pain, dizziness, headache, nasal congestion, cough, rash, and other symptoms may occur during treatment, so caution is advised. Especially in children and adolescents, various adverse reactions such as pharyngitis, influenza, fever, nausea, diarrhea, loss of appetite, and otitis media have been reported, so if symptoms occur, consult a doctor. This medication is not for treating acute asthma attacks; immediate emergency treatment is necessary during acute symptoms, and emergency inhalers should always be on hand. Do not abruptly discontinue inhaled corticosteroids or substitute with this medication; follow your doctor's instructions to gradually reduce the dose. Neuropsychiatric symptoms such as anxiety, agitation, depression, hallucinations, and suicidal thoughts may occur during treatment, so inform your doctor immediately if such symptoms occur. If bronchospasm triggered by exercise occurs, do not treat it only with this medication; continue using inhaled beta-agonists. Patients with hypersensitivity to aspirin or non-steroidal anti-inflammatory drugs should avoid those medications while taking this drug. Rarely, systemic eosinophilia and vasculitis symptoms may appear in asthma patients on this medication, so if symptoms such as eosinophilia, skin rash, or worsening respiratory symptoms occur, seek medical attention. Interactions with other medications are minimal, but caution is needed when taken with certain liver enzyme inducers, so consult your doctor or pharmacist. If pregnant or breastfeeding, avoid use unless clearly necessary, and discuss with a doctor before taking. This medication is intended for use by children and the elderly, but safety and efficacy have not been established in infants under 6 months. In case of overdose, there is no specific antidote, so seek proper medical treatment immediately, and general symptom management is required. Since it is sensitive to light, do not open the packaging until just before administration, and it is best to take it immediately after opening. Store in a place out of reach of children, and do not transfer to other containers. This medication should be taken consistently even if asthma symptoms are absent, and you must consult a doctor if symptoms worsen.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to moisture and light, so it should be stored at room temperature between 1°C and 30°C. Additionally, when not in use, it is important to tightly close the lid to prevent air from entering.
Homogeneous white granules without impurities
4mg/packet, 4mg/packet x 28
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Montelukast Sodium 4.16mg
Prescription medication
NBK Pharmaceutical Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.